These findings agree with lately published data from other research groups, which documented significantly elevated serum NfL levels either in smaller [34, 35] and comparable DM1 cohorts [36], and overall support serum NfL levels as a marker of neuroaxonal damage in DM1. This evidence concerns the gene NEFL and myotonic dystrophy type 1.